Journal of Clinical Pediatrics >
Study on the application value of the new Lake Louise criteria in children with myocarditis
Received date: 2023-04-11
Online published: 2024-06-07
Objective To explore the application value of new Lake Louise criteria (LLC) in the diagnosis of myocarditis in children. Methods The clinical data of children diagnosed with myocarditis (myocarditis group) in Children's Hospital Affiliated to Zhejiang University School of Medicine from May 2019 to December 2020 were retrospectively analyzed. In addition, children who were clinically excluded from myocarditis during the same period were included as non-myocarditis group. Receiver operating characteristic (ROC) curve analysis and calculation of Kappa value were used to compare the diagnostic efficacy of LLC and new LLC in children with myocarditis. Results In the myocarditis group, there were 29 children (16 boys and 13 girls) with a median age of 8.8 (4.2-13.4) years. There were 50 patients (27 boys and 23 girls) in the non-myocarditis group, and the median age was 9.7 (6.2-13.2) years. The T2 mapping value, T1 native value and ECV value of myocarditis group were higher than those of non-myocarditis group, the T1 enhanced value was lower than that of non-myocarditis group, and the difference was statistically significant (P<0.05). The area under ROC curves (AUCs) of LLC, T2 mapping, T1 native, T1 enhanced and ECV for diagnosing myocarditis were 0.75, 0.86, 0.92, 0.70 and 0.93, respectively. The accuracy, sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio of LLC in diagnosing myocarditis were 81.0%, 51.7%, 98.0%, 93.8%, 77.8%, 25.85 and 0.49 respectively. The consistency between LLC and the clinical diagnosis of myocarditis was moderate (Kappa=0.55, P<0.001). The accuracy, sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio of new LLC in diagnosing myocarditis were 92.4%, 89.7%, 94.0%, 89.7%, 94.0%, 14.95 and 0.11 respectively. The consistency between new LLC and the clinical diagnosis of myocarditis was good (Kappa=0.84, P<0.001). Conclusions The new LLC has good application value in the diagnosis of myocarditis in children and can effectively improve the diagnostic efficiency.
Key words： new Lake Louise criteria; myocarditis; magnetic resonance; child
Jiawei LIANG , Xiaohui MA , Xuan JIA . Study on the application value of the new Lake Louise criteria in children with myocarditis[J]. Journal of Clinical Pediatrics, 2024 , 42(6) : 526 -532 . DOI: 10.12372/jcp.2024.23e0289
| [1] | 陈燕, 罗琳, 何健龙, 等. MRI T1 mapping、T2 mapping心肌分段在诊断急性心肌炎中的应用[J]. 中国医学影像学杂志, 2019, 27(8): 599-604. |
| [2] | Haaf P, Garg P, Messroghli DR, et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review[J]. J Cardiovasc Magn Reson, 2016, 18(1): 89. |
| [3] | Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper[J]. J Am Coll Cardiol, 2009, 53(17): 1475-1487. |
| [4] | Schumm J, Greulich S, Wagner A, et al. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis[J]. J Cardiovasc Magn Reson, 2014, 16(1): 14. |
| [5] | 周笛, 庄白燕, 赵世华, 等. 心血管MR诊断心肌炎研究进展: 基于2018《非缺血性心肌炎症诊断CMR标准修改》专家推荐意见[J]. 中国医学影像技术, 2019, 35(10): 1574-1577. |
| [6] | Radunski UK, Lund GK, Stehning C, et al. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging[J]. JACC Cardiovasc Imaging, 2014, 7(7): 667-675. |
| [7] | Bohnen S, Radunski UK, Lund GK, et al. Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure[J]. Circ Cardiovasc Imaging, 2015, 8(6): e003073. |
| [8] | Liu G, Yang X, Su Y, et al. Cardiovascular magnetic resonance imaging findings in children with myocarditis[J]. Chin Med J (Engl), 2014, 127(21): 3700-3705. |
| [9] | Dass S, Suttie JJ, Piechnik SK, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy[J]. Circ Cardiovasc Imaging, 2012, 5(6): 726-733. |
| [10] | 赵世华. 迎接心脏磁共振成像新技术挑战[J]. 中国医学影像技术, 2017, 33(8): 1125-1128. |
| [11] | Luetkens JA, Homsi R, Sprinkart AM, et al. Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(2): 154-161. |
| [12] | Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations[J]. J Am Coll Cardiol, 2018, 72(24): 3158-3176. |
| [13] | 中华医学会儿科学分会心血管学组, 中华医学会儿科学分会心血管学组心肌炎协作组, 中华儿科杂志编辑委员会, 等. 儿童心肌炎诊断建议(2018年版)[J]. 中华儿科杂志, 2019, 57(2): 87-89. |
| [14] | Youn JC, Hong YH, Lee HJ, et al. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study[J]. Eur Radiol, 2017, 27(9): 3924-3933. |
| [15] | 刘钢, 张兴梅, 温兆赢, 等. 心脏磁共振定量组织标记技术对急性心肌炎的诊断价值[J]. 中国医药, 2017, 12(1): 41-45. |
| [16] | 陈文剑, 郭婷婷, 张继良, 等. 心脏磁共振对心肌炎的诊断价值[J]. 中国实用医刊, 2020, 47(9): 5-7. |
| [17] | 欧阳海春, 陈海雄, 胡允兆, 等. 磁共振在急性病毒性心肌炎中的诊断价值[J]. 中华心血管病杂志, 2014, 42(11): 927-931. |
| [18] | Dabir D, Vollbrecht TM, Luetkens JA, et al. Multiparametric cardiovascular magnetic resonance imaging in acute myocarditis: a comparison of different measurement approaches[J]. J Cardiovasc Magn Reson, 2019, 21(1): 54. |
| [19] | Bami K, Haddad T, Dick A, et al. Noninvasive imaging in acute myocarditis[J]. Curr Opin Cardiol, 2016, 31(2): 217-223. |
| [20] | 万俊义. 心脏磁共振钆对比剂延迟强化的临床意义及判断预后的价值[J]. 中国医学影像技术, 2012, 28(8): 1600-1603. |
| [21] | Banka P, Robinson JD, Uppu SC, et al. Cardiovascular magnetic resonance techniques and findings in children with myocarditis: a multicenter retrospective study[J]. J Cardiovasc Magn Reson, 2015, 17: 96. |
| [22] | Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis[J]. JACC Cardiovasc Imaging, 2012, 5(5): 513-524. |
| [23] | Mavrogeni S, Bratis K, Georgakopoulos D, et al. Evaluation of myocarditis in a pediatric population using cardiovascular magnetic resonance and endomyocardial biopsy[J]. Int J Cardiol, 2012, 160(3): 192-195. |
| [24] | Ferreira VM, Piechnik SK, Dall’Armellina E, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging[J]. JACC Cardiovasc Imaging, 2013, 6(10): 1048-1058. |
| [25] | Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping[J]. Cire Cardiovasc Imaging, 2012, 5(1): 102-110. |
| [26] | 殷亮, 喻思思, 龚良庚. 心脏磁共振纵向弛豫时间定量成像技术进展[J]. 中华放射学杂志, 2016, 50(1): 76-78. |
| [27] | Park CH, Choi EY, Kwon HM, et al. Quantitative T2 mapping for detecting myocardial edema after reperfusion of myocardial infarction: validation and comparison with T2-weighted images[J]. Int J Cardiovasc Imaging, 2013, 29(suppl 1): 65-72. |
| [28] | Ding H, Fernandez-de-Manuel L, Sch?r M, et al. Three-dimensional whole-heart T2 mapping at 3T[J]. Magn Reson Med, 2015, 74(3): 803-816. |
| [29] | Lee JJ, Liu S, Nacif MS, et al. Myocardial T1 and extracellular volume fraction mapping at 3 tesla[J]. J cardiovasc Magn Reson, 2011, 13(1): 75. |
| [30] | Kawel N, Nacif M, Zavodni A, et al. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region[J]. J Cardiovasc Magn Reson, 2012, 14(1): 27. |
| [31] | Nadjiri J, Nieberler H, Hendrich E, et al. Performance of native and contrast- enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques[J]. Int J Cardiovasc Imaging, 2017, 33(4): 539- 547. |
| [32] | Wassmuth R, Prothmann M, Utz W, et al. Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema[J]. J Cardiovasc Magn Reson, 2013, 15(1): 27. |
| [33] | 刘新峰, 马海彦, 王荣品, 等. T1 mapping和细胞外容积分数技术在急性病毒性心肌炎的临床应用[J]. 实用医学杂志, 2019, 35(5): 800-803. |
| [34] | Dabir D, Child N, Kalra A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the international T1 multicenter cardiovascular magnetic resonance study[J]. J Cardiovasc Magn Reson, 2014, 16(1): 69. |
| [35] | Miller CA, Naish JH, Bishop P, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume[J]. Circ Cardiovasc Imaging, 2013, 6(3): 373-383. |
| [36] | Cornicelli MD, Rigsby CK, Rychlik K, et al. Diagnostic performance of cardiovascular magnetic resonance native T1 and T2 mapping in pediatric patients with acute myocarditis[J]. J Cardiovasc Magn Reson, 2019, 21(1): 40. |
| [37] | Lurz P, Luecke C, Eitel I, et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-trial[J]. J Am Coll Cardiol, 2016, 67(15): 1800-1811. |
| [38] | Bae?ler B, Schaarschmidt F, Dick A, et al. Mapping tissue inhomogeneity in acute myocarditis: a novel analytical approach to quantitative myocardial edema imaging by T2-mapping[J]. J Cardiovasc Magn Reson, 2015, 17: 115. |
| [39] | Luetkens JA, Homsi R, Dabir D, et al. Comprehensive cardiac magnetic resonance for short-term follow-up in acute myocarditis[J]. J Am Heart Assoc, 2016, 5(7): e003603. |
/
| 〈 |
|
〉 |
